| Online-Ressource |
Verfasst von: | Arslan, Aysenur [VerfasserIn]  |
| Labuhn, Svenja [VerfasserIn]  |
| Sala, Elisa [VerfasserIn]  |
| Ringhoffer, Mark [VerfasserIn]  |
| Schetelig, Johannes [VerfasserIn]  |
| Schröder, Thomas [VerfasserIn]  |
| Bug, Gesine [VerfasserIn]  |
| Franke, Georg-Nikolaus [VerfasserIn]  |
| Stelljes, Matthias [VerfasserIn]  |
| Dreger, Peter [VerfasserIn]  |
| Zeiser, Robert [VerfasserIn]  |
| Teschner, Daniel [VerfasserIn]  |
| Bethge, Wolfgang [VerfasserIn]  |
| Eder, Matthias [VerfasserIn]  |
| Edinger, Matthias [VerfasserIn]  |
| Amann, Elisa Maria [VerfasserIn]  |
| Neuchel, Christine [VerfasserIn]  |
| Schmid-Möglich, Amelie [VerfasserIn]  |
| Schmeller, Sandra [VerfasserIn]  |
| Beyersmann, Jan [VerfasserIn]  |
| Schrezenmeier, Hubert [VerfasserIn]  |
| Mytilineos, Joannis [VerfasserIn]  |
| Kröger, Nicolaus [VerfasserIn]  |
| Fürst, Daniel [VerfasserIn]  |
Titel: | Outcomes of haploidentical transplants with PT-CY vs 10/10 MUD transplants with ATG in Germany |
Verf.angabe: | Aysenur Arslan, Svenja Labuhn, Elisa Sala, Mark Ringhoffer, Johannes Schetelig, Thomas Schröder, Gesine Bug, Georg-Nikolaus Franke, Matthias Stelljes, Peter Dreger, Robert Zeiser, Daniel Teschner, Wolfgang Bethge, Matthias Eder, Matthias Edinger, Elisa Maria Amann, Christine Neuchel, Amelie Schmid-Möglich, Sandra Schmeller, Jan Beyersmann, Hubert Schrezenmeier, Joannis Mytilineos, Nicolaus Kröger, and Daniel Fürst, on behalf of the German Registry for Stem Cell Transplantation |
E-Jahr: | 2024 |
Jahr: | December 10 2024 |
Umfang: | 10 S. |
Illustrationen: | Illustrationen |
Fussnoten: | Online veröffentlicht: 3. Dezember 2024 ; Gesehen am 10.06.2025 |
Titel Quelle: | Enthalten in: Blood advances |
Ort Quelle: | Washington, DC : American Society of Hematology, 2016 |
Jahr Quelle: | 2024 |
Band/Heft Quelle: | 8(2024), 23 vom: Dez., Seite 6104-6113 |
ISSN Quelle: | 2473-9537 |
Abstract: | Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the best curative treatment modality for many malignant hematologic disorders. In the absence of a matched related donor, matched unrelated donors (MUDs) and haploidentical donors are the most important stem cell sources. In this registry-based retrospective study, we compared the outcomes of allo-HSCTs from 10/10 MUDs with antithymocyte globulin (ATG)-based regimens (n = 7050) vs haploidentical transplants (Haplo-Tx) using posttransplant cyclophosphamide (PT-CY Haplo; n = 487) in adult patients with hematologic malignancies between 2010 and 2020. Cox proportional hazard-and competing risks regression models were formed to compare the outcomes. Overall survival (OS), Disease-free survival (DFS), and graft-versus-host disease (GVHD)-free and relapse-free survival (GRFS) were superior for 10/10 MUDs (OS [hazard ratio (HR), 1.27; 95% confidence interval (CI), 1.10-1.47; P = .001]; DFS [HR, 1.17; CI, 1.02-1.34; P = .022]; GRFS [HR, 1.34; CI, 1.19-1.50; P < .001]). The risk of acute GVHD (aGVHD) grade 2 to 4, aGVHD grade 3 to 4, and chronic GVHD (cGVHD) was higher in the PT-CY Haplo group than the 10/10 MUD group (aGVHD grade 2-4 [HR, 1.46; CI, 1.25-1.71; P < .001]; aGVHD grade 3-4 [HR, 1.74; CI, 1.37- 2.20; P < .001]; cGVHD [HR, 1.30; CI, 1.11-1.51; P = .001]). A lower incidence of relapse was observed in the PT-CY Haplo group (relapse: HR, 0.83; CI, 0.69-0.99; P = .038). Unrelated 10/10 matched transplantation with ATG leads to lower GVHD rates and improved survival rates compared with PT-CY Haplo transplantation in Germany. |
DOI: | doi:10.1182/bloodadvances.2024013719 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: https://doi.org/10.1182/bloodadvances.2024013719 |
| DOI: https://doi.org/10.1182/bloodadvances.2024013719 |
Datenträger: | Online-Ressource |
Sprache: | eng |
K10plus-PPN: | 1927856736 |
Verknüpfungen: | → Zeitschrift |
Outcomes of haploidentical transplants with PT-CY vs 10/10 MUD transplants with ATG in Germany / Arslan, Aysenur [VerfasserIn]; December 10 2024 (Online-Ressource)